Syros Pharmaceuticals Inc (NASDAQ:SYRS)

0.919
Delayed Data
As of Aug 17
 -0.051 / -5.26%
Today’s Change
0.65
Today|||52-Week Range
5.64
-71.81%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Syros Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 19.00 and a low estimate of 3.00. The median estimate represents a +444.07% increase from the last price of 0.92.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Syros Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.45
Sales
$4.8M
Reporting Date
Nov 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 16.30%
 
 
 
 
 
 
Growthannually 15.65%
 
 
 
 
 
 

Sales

Growthquarterly -23.20%
 
 
 
 
 
 
Growthannually -12.97%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.